Historical record - last NADAC publication: 1/4/2017

Product Information

ACTOPLUS MET 15 MG-850 MG TAB is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $9.5147 per EA under NDC 64764015860. Its NADAC has been published 171 times since Nov 28, 2013.

ACTOPLUS MET 15 MG-850 MG TAB

pioglitazone and metformin hydrochloride
$9.5147per EA

Strength

850; 15 mg/1; mg/1

NDC

64764015860

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/4/2017

Approval Type

New Drug (NDA)

FDA Application

NDA021842

On Market Since

8/29/2005

Pharmacological Classes

Biguanide
Biguanides
Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for ACTOPLUS MET 15 MG-850 MG TAB has been published 171 times since Nov 28, 2013, and over the history we have for it it has risen 64.7%. The table below summarizes its recorded NADAC range and movement.

Current price$9.5147 per EA
All-time high$9.5147 (Mar 1, 2017)
All-time low$5.7778 (Nov 28, 2013)
Median price$8.4053
Average price$7.8296
Largest weekly change+9.9% (Jul 13, 2016)
Weeks tracked171
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+64.7%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ACTOPLUS MET 15 MG-850 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for ACTOPLUS MET 15 MG-850 MG TAB, manufactured by Takeda Pharmaceuticals America, Inc., is $9.5147 per EA (NDC 64764015860), effective Mar 1, 2017.

How has the price of ACTOPLUS MET 15 MG-850 MG TAB changed over time?

Over the history we have for it, the NADAC for ACTOPLUS MET 15 MG-850 MG TAB has risen 64.7%. It has been tracked across 171 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ACTOPLUS MET 15 MG-850 MG TAB?

Since Nov 28, 2013, the NADAC for ACTOPLUS MET 15 MG-850 MG TAB has ranged from a low of $5.7778 (Nov 28, 2013) to a high of $9.5147 (Mar 1, 2017), with a median of $8.4053 per EA.

Are there cheaper alternatives to ACTOPLUS MET 15 MG-850 MG TAB?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, ACTOPLUS MET 15 MG-850 MG TAB, is $7.6480 per EA — about 20% below ACTOPLUS MET 15 MG-850 MG TAB.

Who manufactures ACTOPLUS MET 15 MG-850 MG TAB?

ACTOPLUS MET 15 MG-850 MG TAB (NDC 64764015860) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.